Tag Search Results: pharmacodiagnostics

Diagnostic tests employed to identify cancer patients eligible for
treatment with targeted therapies, also known af companion diagnostics.

Products (no match found)

 

Service & Support (no match found)

 

Knowledge Center (16)

# Title Description
1Connection 9Page 1. In this issue ER/PR Prognostic and Predictive Factors in Breast Cancer by Immunohistochemistry Craig Allred Image Analysis ...
2Connection 9Page 1. In this issue ER/PR Prognostic and Predictive Factors in Breast Cancer by Immunohistochemistry Craig Allred Image Analysis ...
3Development of pharmacoDiagnostic Tests for Molecular Targeted ... Page 1. Development of pharmacoDiagnostic TM Tests for Molecular Targeted Therapies Yoichi Tani, Yutaka Hatanaka and Kaoru Hashizume Dako Co. Ltd., Kyoto, Japan ...
4Connection 9Page 1. In this issue ER/PR Prognostic and Predictive Factors in Breast Cancer by Immunohistochemistry Craig Allred Image Analysis ...
5Article Pharmacodiagnostic in Breast CancerPage 1. Connection 2008 | 39 T he molecular pathology of cancer is increasingly complex. Novel therapies and greater understanding ...

Show all (16)

About Dako (no match found)

 

Country selection

Your Dako Account indicates that you are based in , you will be transfered to the web site for

Basket emptied

Your basket was emptied because of the country change.

Country selection

United States of America appears to be your location. To view country specific information on the Dako web site, please accept or change country below.



Get in Touch with Dako in Austria

  • Pathology Products
    Dako Österreich GmbH

    info.at@dako.com
    +43 1 408 43 34 0
    +43 1 408 43 36

    Hietzinger Hauptstraβe 50/7
    A-1132 Wien

  • Flow Cytometry Products and Specific Proteins
    Szabo-Scandic HandelsgmbH & Co KG

    mail@szabo-scandic.com
    +43-1-489 3961-0
    +43-1-489 3961-7

    Quellenstraße 110
    1100 Wien

Detailed contact information

Submit an Inquiry

How would you like us to follow up?